Stockreport

Summit Therapeutics Inc (SMMT) Q4 2024 Earnings Call Highlights: Strong Financial Position and ... [Yahoo! Finance]

Summit Therapeutics Inc.  (SMMT) 
Last summit therapeutics inc. earnings: 6/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: summitplc.com/investors/investor-centre
PDF GAAP R&D Expenses: $150.8 million for the full year 2024, up from $59.4 million in the previous year. Non-GAAP R&D Expenses: $134.8 million for the full year 2024, co [Read more]